Boston Biomedical Overview
- Year Founded
-
2006
- Status
-
Acquired/Merged
- Employees
-
30
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$2.63B
Boston Biomedical General Information
Description
Developer of novel cancer therapeutics intended to significantly improve patient outcomes. The company's range of expertise includes drug discovery, external innovation partnerships, medicinal chemistry, preclinical development, pharmacology, pharmaceutical development, CMC (chemistry, manufacturing, and control), global clinical trials, regulatory affairs, and commercialization, enabling physicians to access novel therapeutics for patients with cancer.
Contact Information
Website
www.bostonbiomedical.comCorporate Office
- 640 Memorial Drive
- Cambridge, MA 02139
- United States
Corporate Office
- 640 Memorial Drive
- Cambridge, MA 02139
- United States
Boston Biomedical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 25-Apr-2012 | $2.63B | Completed | Clinical Trials - General | ||
| 1. Early Stage VC (Series A) | 15-Jun-2010 | Completed | Product Development |
Boston Biomedical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Boston Biomedical Comparisons
Industry
Financing
Details
Boston Biomedical Competitors (51)
One of Boston Biomedical’s 51 competitors is Cristal Therapeutics, a Venture Capital-Backed company based in Maastricht, Netherlands.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | ||||
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Intellia Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| CTI BioPharma | Formerly VC-backed | Seattle, WA | ||||
| Apexian Pharmaceuticals | Venture Capital-Backed | Indianapolis, IN |
Boston Biomedical Signals
Boston Biomedical Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mitsui Global Investment | Venture Capital | Minority |
Boston Biomedical FAQs
-
When was Boston Biomedical founded?
Boston Biomedical was founded in 2006.
-
Where is Boston Biomedical headquartered?
Boston Biomedical is headquartered in Cambridge, MA.
-
What is the size of Boston Biomedical?
Boston Biomedical has 30 total employees.
-
What industry is Boston Biomedical in?
Boston Biomedical’s primary industry is Drug Discovery.
-
Is Boston Biomedical a private or public company?
Boston Biomedical is a Private company.
-
What is the current valuation of Boston Biomedical?
The current valuation of Boston Biomedical is .
-
What is Boston Biomedical’s current revenue?
The current revenue for Boston Biomedical is .
-
How much funding has Boston Biomedical raised over time?
Boston Biomedical has raised $3M.
-
Who are Boston Biomedical’s investors?
Mitsui Global Investment has invested in Boston Biomedical.
-
Who are Boston Biomedical’s competitors?
Cristal Therapeutics, CytomX Therapeutics, Intellia Therapeutics, CTI BioPharma, and Apexian Pharmaceuticals are some of the 51 competitors of Boston Biomedical.
-
When was Boston Biomedical acquired?
Boston Biomedical was acquired on 25-Apr-2012.
-
Who acquired Boston Biomedical?
Boston Biomedical was acquired by Sumitomo Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process